John Dormer

Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received

David E. Neal, Chris Metcalfe, Jenny Donovan et al. · European Urology · 2019 · 150 citations · Full text

Medicine, Surgery, Urology +17

Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality

Richard M. Martin, Emma L. Turner, Grace Young et al. · JAMA · 2024 · 95 citations · Full text

Medicine, Oncology, Urology +14

Molecular insights into genome-wide association studies of chronic kidney disease-defining traits

Xiaoguang Xu, James Eales, Artur Akbarov et al. · Nature Communications · 2018 · 73 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression

Richard J. Bryant, Jon Oxley, Grace Young et al. · British Journal of Urology · 2020 · 60 citations · Full text

Medicine, Oncology, Urology +16

The use of ex-vivo normothermic perfusion for the resuscitation and assessment of human kidneys discarded because of inadequate in situ perfusion

Sarah A. Hosgood, Adam D. Barlow, John Dormer et al. · Journal of Translational Medicine · 2015 · 59 citations · Full text

Medicine, Nephrology, Surgery +15